Long‐term outcome of juvenile idiopathic arthritis following a placebo‐controlled trial: sustained benefits of early sulfasalazine treatment

OBJECTIVES: A previous 24‐week randomised trial demonstrated that sulfasalazine (SSZ) treatment was superior to placebo (PLAC) in suppressing disease activity in patients with oligo‐ and polyarticular onset juvenile idiopathic arthritis (JIA). The current study determines the long‐term outcome of th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: van Rossum, Marion A J, van Soesbergen, Renée M, Boers, Maarten, Zwinderman, Aeilko H, Fiselier, Theo J W, Franssen, Marcel J A M, Cate, Rebecca ten, van Suijlekom‐Smit, Lisette W A, Wulffraat, Nico M, van Luijk, Wilma H J, Oostveen, Johanna C M, Kuis, Wietse, Dijkmans, Ben A C
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMJ Group 2007
Aiheet:
Extended Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC2111611/
https://ncbi.nlm.nih.gov/pubmed/17491099
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.064717
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia